期刊文献+

绝经后女性内源性性激素及血脂水平与乳腺癌的关系 被引量:8

Relations of levels of endogenous sex hormones and blood lipids with breast cancer in postmenopausal women
原文传递
导出
摘要 目的:探讨绝经后女性内源性性激素及血脂水平与乳腺癌的关系以及作为预测指标的可行性。方法:收集2011年7月—2014年6月期间手术治疗的绝经后女性乳腺癌患者274例(乳腺癌组)与同期因其他疾病收治的非乳腺疾病的绝经后患者279例(对照组);比较两组间性激素与血脂水平的差异,分析可能的乳腺癌预测指标。结果:乳腺癌组的雌二醇(E2)与睾酮(T)水平明显高于对照组(均P〈0.05),其他性激素与血脂指标两组间差异均无统计学意义(均P〉0.05)。分层分析显示,随E2与T水平升高,乳腺癌发病率增加,其中E2水平对乳腺癌的预测有较好的敏感性和特异性,受试者操作特征(ROC)曲线下面积(AUC)为0.730(95%CI=0.649~0.811),但T水平的预测作用不明显。结论:E2与T水平与绝经后女性乳腺癌有关,其中E2水平可作为预测因子之一,但尚未达到良好或者优秀标准。 Objective:To investigate the relations of the levels of endogenous sex hormones and blood lipids with breast cancer in postmenopausal women and the feasibility of using them as predictors for breast cancer.Methods:Two-hundred and seventy-four postmenopausal women with breast cancer(breast cancer group) undergoing surgical treatment from July 2011 to June 2014,and 279 postmenopausal female patients admitted during the same period for other diseases who were excluded from breast diseases(control group) were enrolled.The levels of sex hormone and blood lipids between the two groups were compared,and the potential predictors for breast cancer were analyzed.Results:The levels of estrogens(E2) and testosterone(T) in breast cancer group were significantly higher than those in control group(both P0.05),while levels of other sex hormones and blood lipids showed no significant difference between the two groups(all P0.05).Stratification analysis demonstrated that the incidence of breast cancer was increased with either E2 level or T level,in which E2 level had a bettersensitivity and specificity for prediction of breast cancer,and its area under curve(AUC) of the receiver operating characteristic(ROC) reached 0.730(95% CI=0.649–0.811),but T level showed no significance in prediction of breast cancer.Conclusion:The E2 and T levels are associated with breast cancer in postmenopausal women,and E2 level can be used as one of the predictors of breast cancer,but has not yet become a satisfactory or excellent standard.
作者 李丹丹
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2015年第5期687-691,共5页 China Journal of General Surgery
关键词 乳腺肿瘤 绝经后期 性腺甾类激素 血脂异常 Breast Neoplasms Postmenopause Gonadal Steroid Hormones Dyslipidemias
  • 相关文献

参考文献22

  • 1Santen RJ, Allred DC, Ardoin SP, et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement[J]. J Clin Endocrinol Metab, 2010, 95(7 Suppl 1):S1-S66.
  • 2Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial[J]. JAMA, 2002, 288(3):321-333.
  • 3Rogers AE. Diet and breast cancer: studies in laboratory animals[J]. J Nutr, 1997, 127(5 Suppl):933s-935s.
  • 4D'Avanzo B, Negri E, Gramenzi A, et a1. Fats in seasoning and breast cancer risk:an Italian case-control study[J]. Eur J Cancer, l99l, 27(4):420-423.
  • 5Potischman N, Weiss HA, Swanson CA, et al. Diet during adolescence and risk of breast cancer among young women[J]. J Natl Cancer Inst, 1998, 90(3):226-233.
  • 6Willett WC. Diet and breast cancer[J]. J Intern Med, 200l, 249(5):395-411.
  • 7Bernstein L, Yuan JM, Ross RK, et a1. Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies[J]. Cancer Causes Control, 1990, 1(1):51-58.
  • 8NCCN Guidelines Version 3. 2014 Breast Cancer[EB/OL]. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
  • 9Swets JA. Measuring the accuracy of diagnostic systems[J]. Science, 1998, 240(4857):1285-1293.
  • 10张厚云,赵凌云.乳腺癌内分泌治疗研究进展[J].中国普通外科杂志,2014,23(5):680-684. 被引量:28

二级参考文献73

  • 1陈伟财,何劲松,王敏,吴恢升,王先明.老年乳腺癌患者新辅助内分泌治疗的临床应用[J].中国癌症杂志,2011,21(5):359-362. 被引量:23
  • 2Jensen EV ,Jacobson HI. Basic guides to the mechanism of estrogen action[J]. Recent Prog Horm Res,1962,18(4) :387.
  • 3Doisneau-Sixou SF, Sergio CM, Carroll JS, et al. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells [ J ]. Endocr Relat Cancer,2003,10 (2) : 179-186.
  • 4Early Breast Cancer Trialists Collaborative Group ( EBCTCG ). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:an overview of the randomised trials[J]. Lancet,2005,365 (9472) : 1687-1717.
  • 5Pagani O, Gelber S, Price K, et al. Toremifene and tamoxifen are equally effeetive for early-stage breast cancer:first results of International Breast Cancer Study Group trials 12-93 and 14-93 [J]. Ann Oncol,2004,15 (12) : 1749-1759.
  • 6Gradishar W, Chia S, Mauriac L, et al. Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer:resuits from EFECT[ J]. J Clin Oncol,2008,26(10) : 1664-1670.
  • 7Miller WR, Dixon JM. Local endocrine effects of aromatase inhibitors with the breast[J]. J Steroid Biochem Mol Biol,2001,79( 1/ 5) :93-102.
  • 8Krainick-Strobel UE, Lichtenegger W, Wallwiener D, et al. Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: a phase Ⅱb/Ⅲ trial to investigate optimal duration of preoperative endocrine therapy [ J ]. BMC Cancer, 2008,26(8) :62.
  • 9Coates AS, Keshaviah A, Thurlimann B, et al. Five years of letrozole compared with tamox/fen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98 [ J ]. J Clin Oncol, 2007, 25 ( 5 ) : 486-492.
  • 10Forbes JF, Cuzick J, Buzdar A, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100- month analysis of the ATAC trial[ J ]. Lancet Oncol, 2008,9 ( 1 ) : 45 -53.

共引文献35

同被引文献51

引证文献8

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部